Not available outside of the UK & Ireland.
Biochem/physiol Actions
Reversible: yes
Product does not compete with ATP.
Target IC50: 230 µM and 240 µM against myosin light chain kinase and Ca2+-calmodulin-dependent phosphodiesterase, respectively.
Cell permeable: yes
General description
A cell-permeable and reversible calmodulin antagonist that inhibits myosin light chain kinase (IC50 = 230 µM) and Ca2+-calmodulin-dependent phosphodiesterase (IC50 = 240 µM).
A cell-permeable and reversible calmodulin antagonist that inhibits Ca2+-calmodulin-dependent phosphodiesterase (IC50 = 240 µM) and myosin light chain kinase (IC50 = 230 µM).
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Packaging
1 mg in Plastic ampoule
Warning
Toxicity: Standard Handling (A)
This product has met the following criteria to qualify for the following awards: